USA

We’ve reached that time of year when washing hands and avoiding errant sneezing particles is essential. Cases of the common cold usually begin in August, but no one wants to sick in the stretch between Thanksgiving and New Year’s when parties are abundant and work becomes less so.

Whimsical edibles will likely temper the clinical respect for medical cannabis, which needs a medical home in the system. Let pharmacists dispense it.

Discover how GreenLight Pharmaceuticals Ltd is aiming to advance clinical research, access and education regarding medical cannabis in Europe. Established in 2014, GreenLight Pharmaceuticals Ltd is an Irish biopharmaceutical company focused on developing safe and effective plant-based medicines. GreenLight specialises in phytocannabinoid research and clinical development. The company is based in Dublin but has recently created a UK based subsidiary and has plans to expand its world of medical cannabis in Europe.

Nov. 26, 2019 -- A warning about possibly contaminated and moldy recreational and medical marijuana has been issued by Colorado officials. The affected marijuana was mistakenly distributed due to a technical error, according to Colorado Department of Revenue news release. It said the error has been corrected, CNN reported. The error occurred between Oct. 21 and Nov. 13, 2019 and the affected marijuana was sold between Oct. 21 and Nov. 14, 2019.

The UK’s first large-scale cannabis study and biggest marijuana health investigation in European history has been announced, raising hopes that many of the country’s health professionals will finally be swayed on the efficacy of the drug for use in treating seven different health conditions.

Prime Minister Mia Amor Mottley today touted the proposed medicinal cannabis industry as a boost to he economy, as a new bill to set it up went before lawmakers.

Israeli cannabis company Cannbit Ltd. will be acquiring the Israeli business of Israeli cannabis grower Tikun Olam Ltd. for NIS 140 million (approximately $40 million), according to several people familiar with the matter who spoke to Calcalist on condition of anonymity. Cannbit won over two rival offers, from Ehud Barak-chaired medical cannabis company InterCure Ltd. and Bazelet Group, who made offers ranging from NIS 80 million to NIS 100 million (approximately $22.7 million to $28.3 million), the people said.

House Bill 136 is Kentucky’s best chance at legalizing medical marijuana. And after gathering momentum throughout 2019, it will be one of the first bills on the legislative agenda in 2020. State Representative Jason Nemes, the bill’s primary co-sponsor, is confident he has the support of enough of his colleagues in the Legislature to move the legalization measure forward with a full vote. Kentucky is one of just 17 U.S. states that do not authorize any medical use of marijuana.

Experts say loosening restrictions and authorizing prescriptions from general practitioners will help more people access medical cannabis treatments for free through NHS.

Endometriosis is a chronic, inflammatory condition where tissue similar to the lining of the uterus is found outside of the womb. It affects around one in ten women of reproductive age, causing pain, infertility and gastrointestinal symptoms. Women often report difficulty getting their pain and other symptoms under control, despite medication or even surgery. Our research, published today, found one in ten Australian women with endometriosis reported using cannabis to manage their pain and other symptoms.

The barriers facing patients accessing medicinal cannabis will be placed under scrutiny during a Parliamentary inquiry into how Australia regulates the drug.

Among professional sports, who would’ve selected golf as the catalyst to shift marijuana policy for athletes? Not us, but golf finds itself in a unique position compared to other sports. While it’s an open secret that football and basketball players use cannabis, we usually only hear about their support for policy change or the launch of their new marijuana brand after these same athletes retire.

A study on the potential role of hemp-derived cannabidiol as an alternative to opioids for pain patients has indicated positive results. Dr Alex Capano, Chief Science Officer of Ecofibre’s Ananda Health business in the United States, led a study involving the use of cannabidiol (CBD) to reduce the use of opioids in the treatment of chronic pain.